Search Results - "Kikuchi, J"

Refine Results
  1. 1

    HDAC inhibitors augment cytotoxic activity of rituximab by upregulating CD20 expression on lymphoma cells by Shimizu, R, Kikuchi, J, Wada, T, Ozawa, K, Kano, Y, Furukawa, Y

    Published in Leukemia (01-10-2010)
    “…Anti-CD20 antibody rituximab is now essential for the treatment of CD20-positive B-cell lymphomas. Decreased expression of CD20 is one of the major mechanisms…”
    Get full text
    Journal Article
  2. 2

    Successful mild brain hypothermia therapy followed by targeted temperature management for pediatric hemorrhagic shock and encephalopathy syndrome by Fujita, Y, Imataka, G, Kikuchi, J, Yoshihara, S

    “…Hemorrhagic shock and encephalopathy syndrome (HSES) is the most severe form of acute encephalopathy that progresses rapidly, often resulting in death or…”
    Get more information
    Journal Article
  3. 3

    Proteasome inhibitors exert cytotoxicity and increase chemosensitivity via transcriptional repression of Notch1 in T-cell acute lymphoblastic leukemia by Koyama, D, Kikuchi, J, Hiraoka, N, Wada, T, Kurosawa, H, Chiba, S, Furukawa, Y

    Published in Leukemia (01-06-2014)
    “…The Notch signaling pathway has been recognized as a key factor for the pathogenesis of T-cell acute lymphoblastic leukemia (T-ALL), because of the high…”
    Get full text
    Journal Article
  4. 4

    Arf tumor suppressor disrupts the oncogenic positive feedback loop including c-Myc and DDX5 by Tago, K, Funakoshi-Tago, M, Itoh, H, Furukawa, Y, Kikuchi, J, Kato, T, Suzuki, K, Yanagisawa, K

    Published in Oncogene (15-01-2015)
    “…Tumor suppressor protein p19 ARF (Arf; p14 ARF in humans) functions in both p53-dependent and -independent modes to counteract hyper-proliferative signals…”
    Get full text
    Journal Article
  5. 5

    Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma by Hatano, K, Kikuchi, J, Takatoku, M, Shimizu, R, Wada, T, Ueda, M, Nobuyoshi, M, Oh, I, Sato, K, Suzuki, T, Ozaki, K, Mori, M, Nagai, T, Muroi, K, Kano, Y, Furukawa, Y, Ozawa, K

    Published in Oncogene (15-01-2009)
    “…Multiple myeloma (MM) is incurable, mainly because of cell adhesion-mediated drug resistance (CAM-DR). In this study, we performed functional screening using…”
    Get full text
    Journal Article
  6. 6

    γ-Secretase inhibitor enhances antitumour effect of radiation in Notch-expressing lung cancer by Mizugaki, H, Sakakibara-Konishi, J, Ikezawa, Y, Kikuchi, J, Kikuchi, E, Oizumi, S, Dang, T P, Nishimura, M

    Published in British journal of cancer (05-06-2012)
    “…Background: Notch receptor has an important role in both development and cancer. We previously reported that inhibition of the Notch3 by γ -secretase inhibitor…”
    Get full text
    Journal Article
  7. 7

    Endobronchial ultrasonography with guide-sheath for peripheral pulmonary lesions by Kikuchi, E, Yamazaki, K, Sukoh, N, Kikuchi, J, Asahina, H, Imura, M, Onodera, Y, Kurimoto, N, Kinoshita, I, Nishimura, M

    Published in The European respiratory journal (01-10-2004)
    “…The usefulness of endobronchial ultrasonography (EBUS) with guide-sheath (GS) as a guide for transbronchial biopsy (TBB) for diagnosing peripheral pulmonary…”
    Get full text
    Journal Article
  8. 8

    Post-occlusional hyperemia for fractional flow reserve assessment and pull-back curve analysis by Hirata, T., Tanigaki, T., Kawase, Y., Hirakawa, A., Omori, H., Okamoto, S., Ota, H., Sobue, Y., Kikuchi, J., Okubo, M., Kamiya, H., Kawasaki, M., Suzuki, T., Pijls, N. H. J., Matsuo, H.

    “…Balloon occlusion is a potential method for inducing hyperemia to measure post-percutaneous coronary intervention (PCI) fractional flow reserve (FFR). The…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Artificial Enzymes by Murakami, Yukito, Kikuchi, Jun-ichi, Hisaeda, Yoshio, Hayashida, Osamu

    Published in Chemical reviews (28-03-1996)
    “…Murakami et al discuss studies on functional simulation of homoenzymes requiring coenzyme factors, such as vitamin B1, B2, B6 and B12. Catalytic performances…”
    Get full text
    Journal Article
  11. 11
  12. 12

    BCR-ABL regulates death receptor expression for TNF-related apoptosis-inducing ligand (TRAIL) in Philadelphia chromosome-positive leukemia by Kuroda, I, Inukai, T, Zhang, X, Kikuchi, J, Furukawa, Y, Nemoto, A, Akahane, K, Hirose, K, Honna-Oshiro, H, Goi, K, Kagami, K, Yagita, H, Tauchi, T, Maeda, Y, Sugita, K

    Published in Oncogene (28-03-2013)
    “…Allogeneic stem cell transplantation (allo-SCT) is a potentially curative therapy for chronic myeloid leukemia and Philadelphia chromosome-positive (Ph(+))…”
    Get full text
    Journal Article
  13. 13
  14. 14

    HOX-mediated LMO2 expression in embryonic mesoderm is recapitulated in acute leukaemias by Calero-Nieto, F J, Joshi, A, Bonadies, N, Kinston, S, Chan, W-I, Gudgin, E, Pridans, C, Landry, J-R, Kikuchi, J, Huntly, B J, Gottgens, B

    Published in Oncogene (28-11-2013)
    “…The Lim Domain Only 2 ( LMO2 ) leukaemia oncogene encodes an LIM domain transcriptional cofactor required for early haematopoiesis. During embryogenesis, LMO2…”
    Get full text
    Journal Article
  15. 15

    Scintillation response of liquid Xe surrounded by PTFE reflector for gamma rays by Yamashita, M., Doke, T., Kawasaki, K., Kikuchi, J., Suzuki, S.

    “…The scintillation response of liquid xenon for gamma rays ranging from 30 to 4000 keV has been measured. The experiment was performed with a double phase Xe…”
    Get full text
    Journal Article
  16. 16

    Pharmacokinetic modelling of serum and bronchial concentrations for clarithromycin and telithromycin, and site-specific pharmacodynamic simulation for their dosages by Ikawa, K., Kikuchi, E., Kikuchi, J., Nishimura, M., Derendorf, H., Morikawa, N.

    “…Summary What is known and objective Clinical pharmacokinetic profiles of clarithromycin and telithromycin in bronchopulmonary sites have not been fully…”
    Get full text
    Journal Article
  17. 17

    Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant by Shimizu, Y, Kinoshita, I, Kikuchi, J, Yamazaki, K, Nishimura, M, Birrer, M J, Dosaka-Akita, H

    Published in British journal of cancer (11-03-2008)
    “…cJun, a major constituent of AP-1 transcription factor transducing multiple mitogen growth signals, is frequently overexpressed in non-small cell lung cancers…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Three-phase PWM boost-buck rectifiers with power-regenerating capability by Kikuchi, J., Lipo, T.A.

    Published in IEEE transactions on industry applications (01-09-2002)
    “…Three-phase pulsewidth-modulated (PWM) boost-buck rectifiers with power-regenerating capability are investigated. The converters under consideration are…”
    Get full text
    Journal Article
  20. 20

    Biodegradation of an endocrine-disrupting chemical, di-2-ethylhexyl phthalate, by Bacillus subtilis No. 66 by Quan, C. S, Liu, Q, Tian, W. J, Kikuchi, J, Fan, S. D

    Published in Applied microbiology and biotechnology (01-03-2005)
    “…A bacterial strain capable of rapidly degrading di-2-ethylhexyl phthalate (DEHP) was isolated from soil and identified as Bacillus subtilis. The organism also…”
    Get full text
    Journal Article